NIHilist's Immunology

How Immune System works

Showing posts with label α-PD1/PD-L1. Show all posts
Showing posts with label α-PD1/PD-L1. Show all posts
Sunday, March 15, 2015

Synergy of checkpoint inhibitors for tumor immunotherapy

›
Introduction of checkpoint inhibitors, α-CTLA4 and α-PD1/PD-L1 humanized antibodies, injected new hope in cancer immunotherapy. Still, the...
›
Home
View web version
Powered by Blogger.